Results 51 to 60 of about 9,572 (201)
Flecainide associated torsade de pointes: A potential case of reverse use dependence
Flecainide has been known to cause torsades de pointes (TdP) in patients with structural heart disease and its mechanism has been attributed to use-dependency.
Kevin Hayes +5 more
doaj
Safety and Efficacy of Pulsed Field Ablation for Atrial Fibrillation in Elderly Patients
Pulsed‐field ablation (PFA) was evaluated in 479 patients with atrial fibrillation (AF), 52% paroxysmal. Among 104 patients > 75 years, complication rates and 6‐ and 12‐month arrhythmia‐free survival were not significantly different from younger patients. Age did not predict recurrence. PFA appears safe and effective in elderly AF patients.
Federico Follesa +8 more
wiley +1 more source
An octogenarian man with a history of multiple catheter ablation failures for atrial fibrillation and tachycardia was diagnosed with transthyretin amyloid cardiomyopathy. After 1 year of tafamidis therapy, the patient experienced spontaneous restoration of sinus rhythm, and follow‐up image of 99mTc‐pyrophosphate scintigraphy revealed a marked decrease ...
Tomoki Horie +4 more
wiley +1 more source
Oral flecainide is effective in management of refractory tachycardia in infants
Background: Propranolol and digoxin have been used as first line drugs for treatment of supraventricular tachycardia (SVT) in infants. Flecainide and other drugs have been effective as a second line treatment for controlling refractory SVT.
Vikas Kohli
doaj +1 more source
Ablation of Ventricular Tachycardia Using the QDOT MICRO Ablation Catheter (VT‐MICRO Study)
Catheter ablation is useful to treat patients with ventricular tachycardia. QDOT Micro catheter is a next generation catheter designed to provide more efficient lesion creation with an accurate myocardial substrate analysis. Microelectrode mapping allows detection of higher voltage electrograms compared to standard bipolar mapping and Pentaray mapping.
Antonio Di Monaco +6 more
wiley +1 more source
Flecainide use in arrhythmic patients who have structural heart disease
Background: Current guidelines recommend the use of only on a limited basis in patients with normal or minimal structural heart disease. The CAST study, the only randomized controlled trials, showed increased mortality from long-term flecainide use in ...
Naruepat Sangpornsuk +5 more
doaj +1 more source
Background: Many subjects in community have non-type 1 Brugada pattern ECG with atypical symptoms, relevance of which is not clear. Provocative tests to unmask type 1 Brugada pattern in these patients would help in diagnosing Brugada Syndrome.
Srinivasa Prasad +9 more
doaj +1 more source
Abstract A 10‐year‐old, female, spayed Pitbull mix presented for evaluation of an arrhythmia. Echocardiography revealed enlargement of all cardiac chambers and decreased left ventricular systolic function. Electrocardiography demonstrated isolated, ventricular premature complexes.
Nathan Mitchell +3 more
wiley +1 more source
BackgroundThere is no consensus on the most effective and best tolerated first‐line antiarrhythmic treatment for fetal tachyarrhythmia. The purpose of this systematic review and meta‐analysis was to compare the efficacy, safety, and fetal–maternal ...
Tarek Alsaied +7 more
doaj +1 more source
Flecainide induced ST segment changes can mimic pathological ECG changes in patients undergoing exercise testing: A case report. [PDF]
Matthias Kruzik +5 more
openalex +1 more source

